United States 119th Congress Status: In Committee Bipartisan · 3 R · 2 D cosponsors

S 3228 — SIMSA Act of 2025

Last action — Read twice and referred to the Committee on the Judiciary.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the Senate. Introduced November 20, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the Senate.

Prognosis

Advancing 40% · moderate confidence

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

  • In Committee

    Current position in the legislative process.

  • 5 sponsors

    1 primary, 4 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (3 R · 2 D) — cross-party backing.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Bill Text

How this bill changes current law

6 changes Share ↗

Compared against current U.S. Code AI-generated reading aid — verify against the official bill.

The bill establishes a new Schedule A for controlled substances and modifies existing regulations regarding the importation and penalties associated with synthetic analogues.

  • 21 U.S.C. § 812

    five schedules of controlled substances, to be known as schedules I, II, III, IV, and V → six schedules of controlled substances, to be known as schedules I, II, III, IV, V, and A

    This change adds a new Schedule A to the existing five schedules of controlled substances.

  • 21 U.S.C. § 812

    (6) Schedule A.-- (A) In general.--The drug or substance-- (i) is or has been imported, or is offered for import, into the United States; (ii) has-- (I) a chemical structure that is substantially similar to the chemical structure of a controlled substance in schedule I, II, III, IV, or V; and (II) an actual or predicted stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in schedule I, II, III, IV, or V; and (iii) is not listed or otherwise included in any other schedule in this section or by regulation of the Attorney General.

    This establishes the criteria for substances to be classified under new Schedule A.

  • 21 U.S.C. § 811

    (k) Temporary and Permanent Scheduling of Schedule A Substances.-- (1) In general.--The Attorney General may issue a temporary order adding a drug or substance to schedule A if the Attorney General finds that-- (A) the drug or other substance satisfies the criteria for being considered a schedule A substance; and (B) adding such drug or substance to schedule A will assist in preventing abuse of the drug or other substance.

    This provision allows for temporary scheduling of substances under Schedule A by the Attorney General.

  • 21 U.S.C. § 960

    or a drug or substance in schedule A

    This change includes Schedule A substances in the existing prohibitions against importing or exporting controlled substances.

  • 21 U.S.C. § 960

    (8) In the case of a violation under subsection (a) involving a controlled substance in schedule A, the person committing such violation shall be sentenced to a term of imprisonment of not more than 20 years and if death or serious bodily injury results from the use of such substance shall be sentenced to a term of imprisonment for any term of years or for life...

    This introduces specific penalties for violations involving Schedule A substances.

  • 21 U.S.C. § 825

    (f) False Labeling of Schedule A Controlled Substances.-- (1) It shall be unlawful to import or export, with intent to manufacture, distribute, or dispense, a schedule A substance or product containing a schedule A substance, unless the substance or product bears a label clearly identifying a schedule A substance or product containing a schedule A substance by the nomenclature used by the International Union of Pure and Applied Chemistry (IUPAC).

    This establishes labeling requirements for Schedule A substances.

Action History

  1. Introduced in Senate

  2. Read twice and referred to the Committee on the Judiciary.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 4 co-sponsors · 542 not signed on

Sponsors (1)

Co-sponsors (4)

Not signed on (542)

542 members have not signed on to this bill.

Show all 542 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors S 3228?
S 3228 is sponsored by Grassley, Chuck (Republican), Hassan, Margaret Wood (Democratic), Ernst, Joni (Republican), Shaheen, Jeanne (Democratic), and Capito, Shelley Moore (Republican).
What is the current status of S 3228?
This bill is in committee in the Senate. Introduced November 20, 2025. It must pass committee before a floor vote.
Where can I track S 3228?
Track S 3228 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on S 3228

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of S 3228

Last checked for changes 4 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →